Some of the other downstream targets of Wnt and ILK pathways, such as c-myc, Lef-1, MMP-2, MMP-7 (data not shown), ser473P-AKT (Additional file 1, Figure S2), did not show a marked difference in expression in the mammary tumors between the two transgenic groups. This evidence concerns the gene MMP2 and breast cancer.